HC, T., HY, L., CY, T., HT, L., MH, C., IL, T., . . . YY, Y. (2026). Cumulative defined daily doses enable objective assessment of treatment intensity and outcome prediction in immunoglobulin G4-related disease and its subtypes. Rheumatology (Oxford, England), 65(4), . https://doi.org/10.1093/rheumatology/keag133
Chicago Style (17th ed.) CitationHC, Tsai, Lu HY, Tsai CY, Liao HT, Chen MH, Tsai IL, Wu LL, and Yang YY. "Cumulative Defined Daily Doses Enable Objective Assessment of Treatment Intensity and Outcome Prediction in Immunoglobulin G4-related Disease and Its Subtypes." Rheumatology (Oxford, England) 65, no. 4 (2026). https://doi.org/10.1093/rheumatology/keag133.
MLA (9th ed.) CitationHC, Tsai, et al. "Cumulative Defined Daily Doses Enable Objective Assessment of Treatment Intensity and Outcome Prediction in Immunoglobulin G4-related Disease and Its Subtypes." Rheumatology (Oxford, England), vol. 65, no. 4, 2026, https://doi.org/10.1093/rheumatology/keag133.